New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dibasic potassium phosphate 54 mg/ml; monobasic potassium phosphate 183 mg/ml - solution for injection - active: dibasic potassium phosphate 54 mg/ml monobasic potassium phosphate 183 mg/ml

Stati Uniti - Ingliż - NLM (National Library of Medicine)

fresenius kabi usa, llc - potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr), potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr) - potassium phosphate, monobasic 224 mg in 1 ml - potassium phosphates injection, usp is indicated as a source of phosphate, for addition to large volume intravenous fluids to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte of nutrient solutions. potassium phosphates is contraindicated in diseases where high potassium, high phosphate or low calcium levels may be encountered.

Kanada - Ingliż - Health Canada

total health centre - potassium phosphate dibasic - liquid - 1x - potassium phosphate dibasic 1x - homeopathic products

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

biomed limited - dibasic potassium phosphate 2 mmol/ml - solution for infusion - 2 mmol/ml - active: dibasic potassium phosphate 2 mmol/ml excipient: water

Stati Uniti - Ingliż - NLM (National Library of Medicine)

hospira, inc. - monobasic potassium phosphate (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr), dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152) - potassium phosphate, monobasic 224 mg in 1 ml - potassium phosphates injection, usp, 3 mm p/ml is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. the concomitant amount of potassium (k+ 4.4 meq/ml) must be calculated into total electrolyte dose of such prepared solutions.     safety has not been established for parenteral nutrition in pediatric patients due to the risk of aluminum toxicity. (see warnings) potassium phosphate is contraindicated in diseases where high potassium, high phosphorus or low calcium levels may be encountered.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

rubimed ag - potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152), copper (unii: 789u1901c5) (copper - unii:789u1901c5), veratrum album root (unii: qns6w5us1z) (veratrum album root - unii:qns6w5us1z), vipera berus venom (unii: 0oro6nca4m) (vipera berus venom - unii:0oro6nca4m), sus scrofa ovary (unii: s7ytv04r8o) (sus scrofa ovary - unii:s7ytv04r8o), bos taurus testicle (unii: pr4rxl6g2h) (bos taurus testicle - unii:pr4rxl6g2h) - potassium phosphate, dibasic 800 [hp_c] in 1 ml - homeopathic combination medicine indications: lack of concentration

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dibasic potassium phosphate, quantity: 183 mg/ml; monobasic potassium phosphate, quantity: 54 mg/ml - injection, concentrated - excipient ingredients: water for injections - indications as at 24 march 2004: treatment of severe hypophosphataemia (serum levels less than 0.3 mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. the cause of hypophosphataemia should be identified and treated.

Kanada - Ingliż - Health Canada

biocentre - potassium phosphate dibasic - tablet - 6x - potassium phosphate dibasic 6x - homeopathic products

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

paragon care group new zealand limited - dibasic potassium phosphate 2 meq/ml; monobasic potassium phosphate 2 meq/ml - solution for infusion - 2 meq/ml - active: dibasic potassium phosphate 2 meq/ml monobasic potassium phosphate 2 meq/ml

Stati Uniti - Ingliż - NLM (National Library of Medicine)

novel laboratories, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic anhydrous (unii: 22ado53m6f) (sodium cation - unii:lyr4m0nh37) - sodium phosphate, monobasic, monohydrate 1.105 g - monobasic sodium phosphate and dibasic sodium phosphate tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. monobasic sodium phosphate and dibasic sodium phosphate tablets are contraindicated in patients with biopsy-proven acute phosphate nephropathy. monobasic sodium phosphate and dibasic sodium phosphate tablets are contraindicated in patients with a known allergy or hypersensitivity to sodium phosphate salts or any of its ingredients. laxatives and purgatives (including monobasic sodium phosphate and dibasic sodium phosphate tablets) have the potential for abuse by bulimia nervosa patients who frequently have binge eating and vomiting.